Susquehanna Fundamental Investments LLC Purchases Shares of 6,005 Encompass Health Co. (NYSE:EHC)

Susquehanna Fundamental Investments LLC acquired a new position in Encompass Health Co. (NYSE:EHC - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 6,005 shares of the company's stock, valued at approximately $555,000.

Several other hedge funds have also modified their holdings of the company. Miracle Mile Advisors LLC grew its position in shares of Encompass Health by 3.0% in the fourth quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company's stock valued at $354,000 after purchasing an additional 112 shares during the period. US Bancorp DE increased its stake in Encompass Health by 9.6% during the 4th quarter. US Bancorp DE now owns 1,380 shares of the company's stock worth $127,000 after buying an additional 121 shares in the last quarter. Signaturefd LLC lifted its position in shares of Encompass Health by 21.6% in the fourth quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after acquiring an additional 125 shares in the last quarter. CBIZ Investment Advisory Services LLC boosted its stake in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after acquiring an additional 127 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB increased its position in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after purchasing an additional 137 shares in the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the company's stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the sale, the insider now owns 11,958 shares in the company, valued at approximately $1,394,422.38. This trade represents a 26.35 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 19,321 shares of company stock valued at $2,142,452. 2.00% of the stock is currently owned by corporate insiders.

Encompass Health Trading Up 0.4 %

Shares of NYSE:EHC traded up $0.51 during midday trading on Wednesday, reaching $117.53. 885,646 shares of the company's stock were exchanged, compared to its average volume of 687,516. The firm's 50 day simple moving average is $102.40 and its two-hundred day simple moving average is $99.52. Encompass Health Co. has a fifty-two week low of $82.74 and a fifty-two week high of $119.07. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The stock has a market cap of $11.84 billion, a price-to-earnings ratio of 26.35, a P/E/G ratio of 2.31 and a beta of 0.91.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The business's revenue was up 10.6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.12 EPS. As a group, sell-side analysts forecast that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.58%. The ex-dividend date is Tuesday, July 1st. Encompass Health's payout ratio is 14.05%.

Analysts Set New Price Targets

Several brokerages have issued reports on EHC. KeyCorp lifted their target price on shares of Encompass Health from $120.00 to $122.00 and gave the stock an "overweight" rating in a research note on Friday, April 25th. Royal Bank of Canada upped their price objective on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research note on Monday, April 28th. Truist Financial reissued a "buy" rating and issued a $135.00 target price (up from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Barclays upped their price target on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research report on Friday, April 25th. Finally, William Blair reissued an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. One research analyst has rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $120.86.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.